$1.9 Billion Global Premature Ejaculation Market Outlook & Forecast 2017-2022 - ResearchAndMarkets.com

DUBLIN--()--The "Premature Ejaculation Market - Global Outlook and Forecast 2017-2022" report has been added to ResearchAndMarkets.com's offering.

The report provides a holistic view of the global premature ejaculation market, the companies involved in the market, and the factors driving its growth. The report also provides information about the latest trends that are likely to become strong market driving forces over the next five years.

The global premature ejaculation market is expected to cross $1.9 billion, growing impressively at a CAGR of 8.9% during the period 2016-2022. Increasing disease awareness, growing patient willingness to seek pharmaceutical therapy assistance for disease management and increasing presence of favorable guidelines, which recommended the use of drugs as first-line therapy for treatment of PE, will augment market prospects during the forecast period.

The amide anesthetics segment is the fast-growing segment in terms of mechanism of action. The oral drug segment to remain the dominant market in terms of route of administration. The topical PE drugs market is expected to witness growth at a higher pace than the oral PE drugs market. However, the oral PE drugs market is likely to retain its market share until the end of the forecast period.

The competitive landscape of the premature ejaculation market is concentrated with select players, which occupy a dominant market share. The rest of the market is composed of a plethora of manufacturers offering a generic version of off-label PE drugs.

Key Vendors

  • Innovus Pharma
  • Plethora Solutions
  • Absorption Pharmaceuticals
  • Allergan

Other Prominent Vendors

  • Menarini
  • GlaxoSmithKline
  • Ixchelsis
  • Dong-A Pharmaceutical
  • NeuroHealing Pharmaceuticals

Key Topics Covered

1 Research Methodology

2 Research objectives

3 Research process

4 Report Coverage

5 Report Assumptions & Caveats

6 Market at a Glance

7 Introduction

8 ISSN Guidelines ON PE

9 Clinical Trial Landscape

10 Pipeline Landscape

11 Marketed Products Landscape

12 Market Dynamics

13 Global Premature Ejaculation Market

14 Premature Ejaculation Market - By Route of Administration

15 Premature Ejaculation Market - By Mechanism of Action

16 Premature Ejaculation Market - By Geography

17 North America: Premature Ejaculation Market

18 Europe: Premature Ejaculation Market

19 APAC: Premature Ejaculation Market

20 Latin America: Premature Ejaculation Market

21 MEA: Premature Ejaculation Market

22 Competitive Landscape

23 Key Company Profiles

24 Other Prominent Companies

25 Report Summary

For more information about this report visit https://www.researchandmarkets.com/research/f69pk5/1_9_billion?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Sexual and Reproductive Health Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Sexual and Reproductive Health Drugs